Advertisement

Topics

Looking back at the biggest deal of 2016: Bayer-Monsanto

04:57 EST 2 Dec 2016 | Pharmafile

The industry followed Bayer’s attempts to acquire US agricultural firm Monsanto with fevered anticipation; the takeover eventually closed in September for $66 billion, debt included. Winckworth Sherwood’s Catherine Moss delves into the implications of the biggest deal of 2016.

The flesh of the deal

read more

Original Article: Looking back at the biggest deal of 2016: Bayer-Monsanto

NEXT ARTICLE

More From BioPortfolio on "Looking back at the biggest deal of 2016: Bayer-Monsanto"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...